Organo-therapeutics.com - Organotherapeutics Company News Section

Organotherapeutics Press Release -

Organo-therapeutics.com

  • Jens Schwamborn about OrganoTherapeutics
  • Prof. Jens Schwamborn co-founded the spin-off project "OrganoTherapeutics" in 2019, which uses 3D brain organoids to research active substances for the treatment of Parkinson's disease.
  • Together with his partner Javier Jarazo, neuroscientist Prof. Jens Schwamborn has been researching the production of 3D brain organoids, also known as ...
  • February 15, 2022
  • Jens Schwamborn's mini brains may reduce amount of animal testing
  • Prof. Jens Schwamborn is developing mini-brains that can be used to research diseases and test active substances more effectively than animal experiments. These could therefore perhaps soon be reduced.
  • In 2019, Prof. Jens Schwamborn founded the company OrganoTherapeutics (http://organo-therapeutics.com/)together with Javier Jarazo as a spin-off of ...
  • December 26, 2021
  • Jens Schwamborn researches the SARS-CoV2 virus on mini brains
  • Jens Schwamborn and his company OrganoTherapeutics are using mini-brains grown in vitro to study the mode of attack of SARS-CoV2 in an environment similar to the human brain and to test active agents against it.
  • Neuroscientist Prof. Jens Schwamborn is actually working on Parkinson's disease research with OrganoTherapeutics (http://organo-therapeutics.com/), a ...
  • December 25, 2021
  • Jens Schwamborn on the future of brain research
  • Prof. Jens Schwamborn works with brain organoids grown in vitro to study neurological diseases such as Parkinson's.
  • Prof. Jens Schwamborn is a neuroscientist and as such deals with the most complex organ of the human body: the brain. And it is precisely this complex ...
  • December 25, 2021